Zydus Lifesciences (ZYDUSLIFE) Share Price Falls 2.11% in Today’s Trade

Published:   31 August 2026 at 11:19:41 AM IST

Zydus Lifesciences Share Price fell to Rs 1,162, down 2.11% from the previous close, while the company’s market capitalisation stood at Rs 1,18,403.70 crore. The move makes Zydus Lifesciences part of today’s stock news in the healthcare space, with the latest share price update showing a clear intraday decline but no company-specific catalyst in the supplied data. In Univest’s coverage, the event is relevant because it combines a same-day share price fall with a sizeable market-cap base and valuation metrics that investors typically track alongside stock news and fundamental analysis. The verified numbers confirm what happened today; they do not establish why the decline occurred.

Zydus Lifesciences (ZYDUSLIFE) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,162
Previous Close	Rs 1,187
Today's Move	-Rs 25.00 (-2.11%)
Open	Rs 1,191.45
High	Rs 1,191.45
Low	Rs 1,159.95
Turnover	Rs 10.34 crore
Market Capitalisation	Rs 1,18,403.7 crore
Market Cap Category	Large Cap

Zydus Lifesciences Share Price Today opened at Rs 1,191.45 and matched the day’s high at the same level before moving lower through the session to a day low of Rs 1,159.95. The stock closed at Rs 1,162, compared with the previous close of Rs 1,187, marking a day change of Rs -25 and a day change percent of -2.11%. Turnover for the session was Rs 10.34 crore. The company is classified as a Large Cap on the supplied market-cap category, and the market capitalisation is Rs 1,18,403.70 crore. For readers following Zydus Lifesciences Stock News, this is a straightforward price fall session with a narrow opening range and a finish near the low. Univest tracks such moves because price action can frame the rest of the stock analysis, especially when the day’s numbers are specific and verified.

The share price fall is best read as an event-led move in the current market session rather than as a broader conclusion about the business. Zydus Lifesciences Share Price Live data shows that the stock remained below its opening level throughout the day, and the gap between the day high and day low was Rs 31.50. That range gives investors a clean snapshot of the intraday move. On a company-size basis, the Large Cap category places the stock in a well-established market-cap bucket, and the same-day decline is therefore notable in the context of its scale. Zydus Lifesciences Share Price News today is about the verified fall, the closing level and the exact trade values; it is not about an assumed trigger. For stock market today watchers, the next step is to place that move alongside fundamentals and sector context.

Zydus Lifesciences (ZYDUSLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,18,403.7 crore
P/E Ratio	26.24x
P/B Ratio	4.39x
ROE	19.69%
ROCE	21.39%
EPS	Rs 45.24
Book Value Per Share	Rs 270.31
Dividend Yield	0.08%

Zydus Lifesciences Fundamental Analysis shows a market capitalisation of Rs 1,18,403.70 crore, an enterprise-scale listed business with a P/E ratio of 26.24 and a P/B ratio of 4.39. The stock’s ROE is 19.69% and ROCE is 21.39%, both of which are useful profitability and capital-efficiency measures. EPS stands at Rs 45.24, book value per share at Rs 270.31 and dividend yield at 0.08%. These are all exact supplied figures and together they offer a more complete view of Zydus Lifesciences Share Price than the daily decline alone.

In Univest’s view, the key question for stock news readers is whether the valuation sits in line with the business quality metrics. The company’s P/E of 26.24 is below the industry benchmark median of 31.21 for the same industry, while the P/B of 4.39 is above the benchmark median of 2.88. ROE at 19.69% and ROCE at 21.39% are both above the benchmark medians of 11.78% and 13.6%. That mix suggests that Zydus Lifesciences Share Price is being assessed against solid profitability metrics, even as the market is digesting today’s decline. EPS, book value and dividend yield add authenticity to the numbers: earnings per share are Rs 45.24, the accounting net worth per share is Rs 270.31, and dividend yield is 0.08%.

The company’s fundamentals therefore add context to today’s fall without explaining it away. Zydus Lifesciences Stock News is more meaningful when the valuation ratios and return metrics are set against peers and sector medians, because those comparisons show how the stock is positioned within pharmaceuticals & drugs. For Univest readers tracking Zydus Lifesciences Latest News, this section is the bridge from the day’s share price fall to a more durable financial analysis.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	26.24x
Benchmark Median P/E	31.21x
Benchmark Average P/E	48.1x
Benchmark P/E Range	3.7x to 672.45x
Company P/B Ratio	4.39x
Benchmark Median P/B	2.88x
Benchmark Average P/B	4.19x
Company ROE	19.69%
Benchmark Median ROE	11.78%
Benchmark Average ROE	10.68%
Company ROCE	21.39%
Benchmark Median ROCE	13.6%
Benchmark Average ROCE	13.27%
Company Market Capitalisation	Rs 1,18,403.7 crore
Benchmark Median Market Cap	Rs 670.73 crore
Benchmark Average Market Cap	Rs 14,040.53 crore

Within Healthcare and the Pharmaceuticals & Drugs industry, Zydus Lifesciences Share Price sits in a benchmark set of 203 companies. The company’s P/E of 26.24 is below the benchmark median P/E of 31.21 and also below the benchmark average of 48.1. Its P/B of 4.39 is above the benchmark median P/B of 2.88 and above the benchmark average of 4.19. ROE at 19.69% is above the benchmark median of 11.78%, and ROCE at 21.39% is above the benchmark median of 13.6%. Those comparisons are useful for anyone following Zydus Lifesciences Stock Analysis because they show where the company stands within its industry on a like-for-like basis.

The sector snapshot also gives market-cap context. The company’s market capitalisation of Rs 1,18,403.70 crore is well above the benchmark median market capitalisation of Rs 670.73 crore and above the benchmark average of Rs 14,040.53 crore for the same industry set. In sector terms, that places Zydus Lifesciences among larger listed names in its peer universe, which is important when reading Zydus Lifesciences Share Price Today alongside the industry benchmark. Univest uses this kind of comparison to make stock news easier to interpret: the share price fall is one part of the picture, while the industry medians, averages and range provide the wider context.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,60,696.31	38.09	5.33	14.85	19.11
Divi's Laboratories	DIVISLAB	2,46,062.83	84.12	13.93	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,91,515.22	87.81	21.34	26.76	19.27
Cipla	CIPLA	1,14,554.33	33.99	3.26	11.83	16
Laurus Labs	LAURUSLABS	1,04,566.62	95.64	18.54	18.31	18.2

Zydus Lifesciences Share Price can be compared with peers such as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Laurus Labs, Lupin, Mankind Pharma, Dr. Reddy’s Laboratories and Aurobindo Pharma Among the supplied peer set, Zydus Lifesciences has a market capitalisation of Rs 1,18,403.70 crore, which is below Sun Pharmaceutical’s Rs 4,60,696.31 crore and Divi’s Laboratories’ Rs 2,46,062.83 crore, but above Cipla’s Rs 1,14,554.33 crore and several other listed peers.

On valuation, Zydus Lifesciences Share Price is marked by a P/E of 26.24, lower than Sun Pharmaceutical’s 38.09, Divi’s Laboratories’ 84.12, Torrent Pharmaceuticals’ 87.81, Cipla’s 33.99 and Laurus Labs’ 95.64, while also above Lupin’s 17.99. On return metrics, ROE at 19.69% is stronger than Sun Pharmaceutical, Divi’s Laboratories, Cipla and Dr. Reddy’s Laboratories, though below Lupin and Torrent Pharmaceuticals. ROCE at 21.39% is above Sun Pharmaceutical, Cipla, Dr. Reddy’s Laboratories and Aurobindo Pharma, and close to Divi’s Laboratories. For Univest readers, this makes Zydus Lifesciences Stock News more nuanced than a one-day fall: the stock is declining today, but its peer metrics show a mixed picture rather than a uniform one.

Why Investors Are Watching Zydus Lifesciences

• Zydus Lifesciences Share Price fell 2.11% today to Rs 1,162 from Rs 1,187.
• The day’s open was Rs 1,191.45 and the low was Rs 1,159.95.
• Turnover for the session was Rs 10.34 crore.
• Market capitalisation stood at Rs 1,18,403.70 crore, and the stock is classified as Large Cap.
• P/E is 26.24, P/B is 4.39, ROE is 19.69% and ROCE is 21.39%.

About Zydus Lifesciences

Zydus Lifesciences operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places the company in the Large Cap category and shows that it is followed alongside other listed pharmaceutical names in the same industry. For readers tracking Zydus Lifesciences Stock Performance, the company description here is intentionally factual and to the verified sector and industry classification supplied in the dataset. That keeps Zydus Lifesciences Share News anchored to the data used in this article and avoids unsupported expansion.

Track Zydus Lifesciences Share Price on Univest

Use Zydus Lifesciences (ZYDUSLIFE) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Univest lets you track Zydus Lifesciences Share Price, Zydus Lifesciences Share Price Today, Zydus Lifesciences Stock News and Zydus Lifesciences Share Price Live in one place. You can also review key ratios, shareholding pattern, 52-week levels and market insights on Univest for a fuller stock analysis experience.

Frequently Asked Questions

Why did Zydus Lifesciences Share Price fall today?

Ans.  The supplied data confirms that Zydus Lifesciences Share Price fell 2.11% today, but it does not establish a company-specific catalyst. The session closed at Rs 1,162 versus Rs 1,187 previously.

What is Zydus Lifesciences Share Price Today?

Ans.  Zydus Lifesciences Share Price Today is Rs 1,162. The stock moved down Rs 25 from the previous close of Rs 1,187, and the day’s range ran from Rs 1,159.95 to Rs 1,191.45.

What does Zydus Lifesciences stock news show about valuation?

Ans.  Zydus Lifesciences Stock News shows a P/E of 26.24 and a P/B of 4.39. In the same industry set, the P/E is below the benchmark median, while P/B is above the benchmark median.

How does Zydus Lifesciences compare with healthcare peers?

Ans.  Zydus Lifesciences has a market cap of Rs 1,18,403.70 crore, below Sun Pharmaceutical and Divi’s Laboratories but above Cipla. Its ROE of 19.69% is also stronger than several listed peers.

What do the fundamentals say about Zydus Lifesciences Share Price?

Ans.  Zydus Lifesciences Share Price is backed by EPS of Rs 45.24, book value of Rs 270.31 and dividend yield of 0.08%. ROE at 19.69% and ROCE at 21.39% add further context.